A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo

Published:2019-04 Issue:2 Volume:512 Page:276-282
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Liu Jinrong,Yang Dazhen,Yin Zhengna,Gao Mengyun,Tong Hua,Su Yiping,Zhu Jin,Ye Chunping,Zhang Huilin

Funder

Nanjing Medical Science and Technique Development Fund

Jiangsu Provincial Medical Youth Talent

Jiangsu Provincial Key Research and Development Program

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. Ovarian cancer statistics, 2018;Torre;CA A Cancer J. Clin.,2018

2. Real-world evidence in the treatment of ovarian cancer;Eisenhauer;Ann. Oncol. : Off. J. Eur. Soc. Med. Oncol, / ESMO,2017

3. Targeted therapy in cancer;Tsimberidou;Cancer Chemother. Pharmacol.,2015

4. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody;Aung;World J. Gastroenterol. : WJG,2018

5. Upregulation of Trop-2 quantitatively stimulates human cancer growth;Trerotola;Oncogene,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trop2-targeted therapies in solid tumors: advances and future directions;Theranostics;2024

2. Targeting Trop2 in solid tumors: a look into structures and novel epitopes;Frontiers in Immunology;2023-12-20

3. Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2;International Journal of Biological Macromolecules;2023-12

4. Comparison of Anti-Trop2 Extracellular Domain Antibodies Generated Against Peptide and Protein Immunogens for Targeting Trop2-Positive Tumour Cells;Applied Biochemistry and Biotechnology;2023-09-01

5. Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging;Biomedicines;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3